Kamat Hotels (India) Ltd
NSE:KAMATHOTEL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kamat Hotels (India) Ltd
NSE:KAMATHOTEL
|
IN |
|
F
|
Firm Capital Apartment Real Estate Investment Trust
OTC:FCAFF
|
CA |
|
Unibail-Rodamco-Westfield SE
OTC:UNBLF
|
FR |
|
A
|
Agile Therapeutics Inc
F:0AL
|
US |
|
Broedrene A & O Johansen A/S
CSE:AOJ B
|
DK |
|
Naturhouse Health SA
F:2NH
|
ES |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
CN |
|
T
|
Tinexta SpA
F:7T4
|
IT |
|
Hyliion Holdings Corp
NYSE:HYLN
|
US |
|
John Lewis of Hungerford PLC
LSE:JLH
|
UK |
|
Alset Capital Inc
XTSX:GPUS
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is KAMATHOTEL's stock price target?
Not Available
KAMATHOTEL doesn't have any price targets made by Wall Street professionals.
What is Kamat Hotels (India) Ltd's Revenue forecast?
Projected CAGR
-6%
For the last 13 years the
compound annual growth rate for
Kamat Hotels (India) Ltd's revenue is
6%.
The projected
CAGR
for the next 13 years is
-6%.